Breaking News Instant updates and real-time market news.

M

Macy's

$24.20

0.4 (1.68%)

, AMZN

Amazon.com

$1,176.75

15.48 (1.33%)

11:05
12/01/17
12/01
11:05
12/01/17
11:05

Macy's boosts holiday hiring plans after 'great start'

Shares of Macy's (M) were given a boost after the retailer said it had a strong start to the holiday season and said it would hire an additional 7,000 seasonal workers. ADDITIONAL SEASONAL HIRES: Macy's said this morning that it will hire an additional 7,000 temporary workers for positions at its stores across the U.S. for the Christmas and holiday season. In anticipation of continuing demand and strong traffic, the company is adding associates "to ensure that customers continue to receive the high level of service they have come to expect from us," said John Harper, Macy's chief stores officer, adding that "Macy's has had a great start to this holiday season with high customer volume across our business." In September, Macy's announced plans to hire about 80,000 seasonal workers, fewer than it hired for the 2016 holiday season. Macy's operates 70 fewer stores than it did last year. WHAT'S NOTABLE: Macy's and other retailers and department stores have been hurt by the increasing popularity of fast-fashion retailers like Zara, Forever 21 and H&M, as well as an increase in online shopping on sites such as Amazon (AMZN). Macy's has permanently lowered its headcount through the closure of 100 stores, which is expected to be completed by the end of 2017. According to comScore, U.S. desktop retail e-commerce spending for Thanksgiving Day and Black Friday 2017. Thanksgiving Day saw a 22% gain to $1.57B in spending, while Black Friday followed with an even stronger spending day with $2.36B in desktop online sales, up 20% from Black Friday 2016. Macy's was one of the top online shopping sites during the period, comScore said. In November, Macy's reported a mixed quarter, but backed its sales and earnings guidance for FY17, with CEO Jeff Gennette saying, "We are excited about our plans for holiday, which is when Macy's truly shines as a gifting destination." PRICE ACTION: Macy's was up 1.2% to $24.08 in morning trading, though shares are down over 32% year-to-date. OTHERS TO WATCH: Other retailers trading higher this morning include J.C. Penney (JCP), Kohl's (KSS) and Sears (SHLD), which reported a better than expected third quarter yesterday.

M

Macy's

$24.20

0.4 (1.68%)

AMZN

Amazon.com

$1,176.75

15.48 (1.33%)

JCP

J.C. Penney

$3.42

0.1055 (3.19%)

KSS

Kohl's

$48.16

0.19 (0.40%)

SHLD

Sears

$4.08

-0.13 (-3.09%)

  • 08

    Jan

  • 18

    Mar

M Macy's
$24.20

0.4 (1.68%)

10/17/17
MSCO
10/17/17
NO CHANGE
MSCO
Survey points to Amazon gaining traction in apparel, says Morgan Stanley
Morgan Stanley analyst Kimberly Greenberger said the results of the firm's latest apparel survey lend support to her belief that Amazon (AMZN) is quickly gaining traction in the space at the expense of department stores and select specialty retailers. Nordstrom (JWN) and Macy's (M) showed above average risk with 84% and 81% Amazon shopper overlap, noted Greenberger. She also noted that Urban Outfitters' (URBN) Anthropologie, Abercrombie & Fitch (ANF) and Gap's (GPS) Banana Republic were among the brands that registered declines in respondents' net purchase intentions over the next 12 months.
10/30/17
SBSH
10/30/17
DOWNGRADE
Target $16
SBSH
Sell
Macy's downgraded to Sell from Neutral at Citi
Citi analyst Paul Lejuez downgraded Macy's (M) to Sell and cut his price target for the shares to $16 from $21. The retailer's sales and margins have been pressured for several years, and J.C. Penney's (JCP) weak Q3 preannouncement on Friday serves as reminder of just how challenging the department store space is, Lejuez tells investors in a research note. He believes risks are mounting at Macy's ahead of what is likely to be another promotional holiday season. Macy's has not found the right tools to offset negative store traffic and margin pressures, the analyst contends. Lejuez this morning also downgraded Penny to Sell.
10/30/17
10/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. General Motors (GM) downgraded to Sell from Neutral at Goldman Sachs with analyst David Tamberrino saying his price target of $32 offers 28% potential downside. The analyst continues to believe the North America auto cycle has peaked and he remains cautious on the sector. 2. Merck (MRK) downgraded to Hold from Buy at SunTrust and to Equal Weight from Overweight at Morgan Stanley, as well as Barclays. 3. J.C. Penney (JCP) downgraded to Sell from Neutral at Citi, to Neutral from Buy at Northcoast, and to Neutral from Positive at Susquehanna. 4. Macy's (M) downgraded to Sell from Neutral at Citi with analyst Paul Lejuez saying the retailer's sales and margins have been pressured for several years, and J.C. Penney's weak third quarter preannouncement on Friday serves as reminder of just how challenging the department store space is. 5. Under Armour (UAA, UA) downgraded to Underperform from Neutral at BofA/Merrill with analyst Robert Ohmes saying he expects management to lower fourth quarter guidance on its Q3 conference call due to the highly promotional environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/09/17
JEFF
11/09/17
NO CHANGE
Target $20
JEFF
Hold
Jefferies sees some 'green shoots,' trims Macy's target to $20
Jefferies analyst Randal Konik says closely managed inventory lead to gross margin upside in Macy's Q3, which offset comp weakness. The analyst likes Macy's steps to drive traffic with initiatives across marketing, merchandising, and omni capabilities. He remains "guarded," however, around the secular headwinds in the mall-based department store space. In a post-earnings research note titled "Some Green Shoots Here, But We Remain Guarded L-Term," Konik lowered his price target for Macy's shares to $20 from $21 and keeps a Hold rating on the name.
AMZN Amazon.com
$1,176.75

15.48 (1.33%)

12/01/17
WELS
12/01/17
NO CHANGE
WELS
Wells not seeing Amazon talks as good news for Mylan, others
CNBC last night reported that Amazon.com (AMZN) is in exploratory talks with Mylan (MYL) and Novartis' Sandoz (NVS) regarding a potential entry into the pharmacy space. While the market might consider this good news for Mylan and other generics as a sign of potential preferred supplier agreements, Wells Fargo analyst David Maris says he's more cautious. Amazon entering the pharmacy market could be a negative headwind for retail generics and potentially branded over-the-counter products, Maris argues. He believes Amazon would source at competitive prices and that "increased price transparency may cause traditional retailers to push harder for price concessions."
12/01/17
WELS
12/01/17
NO CHANGE
Target $1525
WELS
Outperform
Amazon price target raised to $1,525 from $1,430 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for Amazon.com (AMZN) to $1,525 to reflect increased outer-year estimates for Web Services as well as a higher sum-of-the-parts valuation. The stock closed yesterday up $15.48 to $1,176.75. The analyst highlights the "very successful" five-day Amazon Wed Services conference in Las Vegas, "record-breaking" early holiday sales data, and another healthcare industry development with CNBC reporting the company is in talks with generic manufacturers Mylan (MYL) and Novartis (NVS). Sena sees an increasing likelihood that Amazon "ultimately becomes a disruptor" in healthcare, with generics representing a potential point of entry. The Wells Fargo Healthcare team sees generics as a "simple entry point" in pharma as it involves many players with ready supply and a price competitive market, Sena tells investors in a research note. The analyst keeps an Outperform rating on Amazon.
12/01/17
OPCO
12/01/17
NO CHANGE
Target $1330
OPCO
Outperform
Amazon.com price target raised to $1,330 from $1,165 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Amazon.com to $1,330 after the company's Web Services announced dozens of new services focused on databases, Internet-of-Things and serverless functionality. AWS is now well positioned to be the platform company for IoT and democratizing artificial intelligence, Helfstein tells investors in a research note. The analyst believes Amazon's pace of innovation is strong and keeps an Outperform rating on the name.
12/01/17
NRCS
12/01/17
NO CHANGE
Target $52.5
NRCS
Buy
Aaron's working to leverage Amazon traffic and mindshare, says Northcoast
Northcoast analyst Nick Mitchell said channel work indicates Aaron's (AAN) Progressive segment is working diligently to put together a scalable go-to-market strategy that would allow it to leverage Amazon's (AMZN) traffic and mindshare. The analyst believes Progressive's market leading position will translate into significant growth over the next 5 to 10 years and thinks Amazon could conservatively represent a $240M to $721M inventory outsourcing opportunity, or operating income in the range of $45M to $218M. Mitchell views this as another good reason to own the stock at these levels and reiterates his Buy rating and $52.50 price target on Aaron's.
JCP J.C. Penney
$3.42

0.1055 (3.19%)

11/13/17
SBSH
11/13/17
NO CHANGE
Target $1.5
SBSH
Sell
J.C. Penney quarter raises several concerns, says Citi
Although the better than expected sales in J.C. Penney's Q3 led to a short squeeze, the quarter raised several concerns, Citi analyst Paul Lejuez tells investors in a post-earnings research note. Transactions were still down even with all the promotions and higher penetration of credit in appliances is a risk, the analyst contends. Further, he believes the comp boost from appliances is likely to slow meaningfully in Q4. Lejuez continues to believe Penny's "high amount of debt on the business leaves little value left for equity holders." He keeps a Sell rating on the shares with a $1.50 price target.
11/30/17
COWN
11/30/17
NO CHANGE
Target $4
COWN
Market Perform
J.C. Penney taking steps toward a comeback, says Cowen
Cowen analyst Oliver Chen met with J.C. Penney and said he is confident the company's liquidity, its multi-year ability to drive free cash flow, and controlled capital expenditures will mitigate some risk. He likes management's simplification of marketing, its value messaging and execution, and leveraging of non-apparel categories, which should drive greater consistency in traffic and growth. Chen maintains his Market Perform rating and $4 price target on J.C. Penney shares as he looks for visibility on greater consistency in traffic trends.
10/30/17
NRCS
10/30/17
DOWNGRADE
NRCS
Neutral
J.C. Penney downgraded to Neutral from Buy at Northcoast
KSS Kohl's
$48.16

0.19 (0.40%)

11/29/17
DADA
11/29/17
NO CHANGE
Target $1500
DADA
Buy
Amazon.com price target raised to $1,500 from $1,300 at DA Davidson
DA Davidson analyst Tom Forte raised his price target on Amazon (AMZN) shares to $1,500 from $1,300 after increasing his long-term sales forecast to a 9.8% CAGR from 8.6% based on his rising confidence in the company's ability to leverage physical stores to maximize its long-term revenue growth. Amazon's increased physical footprint, including its Whole Foods buy, book stores, and Kohl's (KSS) partnership, is "THE story of its 2017 holiday sales and an indication of things to come," Forte tells investors. The analyst, who thinks Amazon could another 1,000 plus physical locations and acquire an apparel retailer, such as lululemon (LULU), keeps a Buy rating on the e-commerce giant's shares.
11/24/17
RHCO
11/24/17
NO CHANGE
RHCO
American Eagle, Old Navy look like holiday 'winners' based on SunTrust checks
SunTrust analyst Pamela Quintiliano said the mall she visited during her Thanksgiving checks was the most crowded she has seen on the holiday in years and that American Eagle (AEO) and Gap's (GPS) Old Navy appeared to be "winners" as they consistently had the longest register lines. Among big box retailers visited, Wal-Mart (WMT) and Kohl's (KSS) had more activity than others, added Quintiliano.
11/10/17
11/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CVS Health (CVS) upgraded to Buy from Hold at Needham with analyst Kevin Caliendo saying the stock's risk/reward is favorable, especially if CVS is able to consummate the reported merger with Aetna (AET). 2. Kohl's (KSS) upgraded to Outperform from Neutral at Baird with analyst Mark Altschwager saying Kohl's improving product portfolio and strong loyalty position the company for the holiday season, while cost savings and inventory reductions provide free-cash-flow visibility near-term. 3. Fiat Chrysler (FCAU) upgraded to Neutral from Sell at Citi. 4. Comcast (CMCSA) upgraded to Action List Buy from Buy at TD Securities. 5. Hyatt (H) upgraded to Buy from Hold at Berenberg with analyst Stuart Gordon saying the potential returns from the company's real estate disposals are being underappreciated. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/10/17
BARD
11/10/17
UPGRADE
Target $47
BARD
Outperform
Kohl's upgraded to Outperform at Baird
As reported ealrier, Baird upgraded Kohl's (KSS) to Outperform from Neutral and increased its price target to $47 from $46. Analyst Mark Altschwager said Kohl's improving product portfolio and strong loyalty position the company for the holiday season, while cost savings and inventory reductions provide free-cash-flow visibility near-term. The analyst notes most of Kohl's stores are in strip/freestanding locations that provide close and convenient physcial locations enabling omni-channel experiences that ecommerce models and mall based retailers can't offer, illustrated by Amazon's (AMZN) partnership with Kohl's. Additionally, Altschwager expects Q3 comp pressures to abate Q4 and for traffic/comps to stabilize.
SHLD Sears
$4.08

-0.13 (-3.09%)

07/21/17
RHCO
07/21/17
NO CHANGE
RHCO
Amazon.com, Sears deal doesn't impact Best Buy thesis, says SunTrust
After Best Buy (BBY) dropped following the announcement of a deal between Amazon (AMZN) and Sears (SHLD) on appliances, SunTrust analyst David Magee says the 4% decline in Best Buy's stock is "understandable." However, he says the news doesn't alter his basic thesis on Best Buy. Magee says that Best Buy has shown that it can compete effectively against Amazon in other categories, while there are several other brands of appliances besides Sears' Kenmore that have good reputations and Best Buy will have better service than Sears and Amazon. He keeps a $70 price target and a Buy rating on Best Buy.
12/01/17
SUSQ
12/01/17
NO CHANGE
Target $3
SUSQ
Negative
Sears doubtful to remain a going concern, says Susquehanna
Susquehanna analyst Bill Dreher said Sears will continue to pare assets, reduce expenses, and lower head count in its attempt to survive, but he noted the amount of saleable assets is finite and its sales continue to fall faster than expenses. He remains concerned about the company's ability to remain a going concern. Dreher reiterated his Negative rating and lowered his price target to $3 from $4 on Sears shares.
10/24/17
LOOP
10/24/17
NO CHANGE
Target $72
LOOP
Buy
Whirlpool leaving Sears positive for Best Buy, says Loop Capital
Loop Capital analyst Anthony Chukumba views Whirlpool (WHR) no longer offering appliances in Sears (SHLD) stores or online as "another incremental positive" for Best Buy (BBY). While picking up Whirlpool sales will have a "relatively insignificant impact" on Best Buy's annual earnings, Sears can no longer claim it carries all of the major U.S. appliance brands, which should accelerate its market share losses, Chukumba tells investors in a research note. He thinks Sears is "inching closer and closer" to a bankruptcy and reiterates a Buy rating on Best Buy with a $72 price target. The stock in morning trading is up 87c to $56.89.
08/25/17
SUSQ
08/25/17
NO CHANGE
SUSQ
Sears core 'bad, getting worse, ' says Susquehanna
Susquehanna says that Sears' Q2 results show that its core business is "bad and getting worse," and the firm doubts "whether the company will ever" generate comp sales growth again. Susquehanna says that the company "is struggling to exist" and keeps a $4 price target and Negative rating on the stock.

TODAY'S FREE FLY STORIES

RIGL

Rigel Pharmaceuticals

$3.57

-0.15 (-4.03%)

07:14
12/15/17
12/15
07:14
12/15/17
07:14
Initiation
Rigel Pharmaceuticals initiated  »

Cantor sees FDA approval…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

CRTO

Criteo

$24.42

-7.19 (-22.75%)

07:12
12/15/17
12/15
07:12
12/15/17
07:12
Downgrade
Criteo rating change  »

Criteo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

07:11
12/15/17
12/15
07:11
12/15/17
07:11
Recommendations
Oracle analyst commentary  »

Oracle business momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIPR

Innovative Industrial Properties

$22.60

2.28 (11.22%)

07:10
12/15/17
12/15
07:10
12/15/17
07:10
Hot Stocks
Innovative Industrial Properties raises quarterly dividend to 25c per share »

Innovative Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLX

Hologic

$42.96

-0.72 (-1.65%)

07:08
12/15/17
12/15
07:08
12/15/17
07:08
Recommendations
Hologic analyst commentary  »

Hologic positioned well…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFGC

Performance Food Group

$30.55

-0.9 (-2.86%)

07:07
12/15/17
12/15
07:07
12/15/17
07:07
Earnings
Performance Food Group sees FY18 adjusted EPS up 13%-18% »

For fiscal 2018, PFG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

TYME

Tyme Technologies

$3.30

0.05 (1.54%)

07:05
12/15/17
12/15
07:05
12/15/17
07:05
Initiation
Tyme Technologies initiated  »

Tyme Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

, SNY

Sanofi

$43.09

-0.83 (-1.89%)

07:04
12/15/17
12/15
07:04
12/15/17
07:04
Hot Stocks
Alnylam announces lift of FDA clinical hold on Fitusiran »

Alnylam Pharmaceuticals…

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

SNY

Sanofi

$43.09

-0.83 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Mar

  • 02

    May

UA

Under Armour; also tag UAA

$12.45

0.09 (0.73%)

, UAA

Under Armour; also tag UA

$13.82

0.2 (1.47%)

07:04
12/15/17
12/15
07:04
12/15/17
07:04
Upgrade
Under Armour; also tag UAA, Under Armour; also tag UA rating change  »

Under Armour upgraded to…

UA

Under Armour; also tag UAA

$12.45

0.09 (0.73%)

UAA

Under Armour; also tag UA

$13.82

0.2 (1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBA

Ritchie Bros.

$28.69

0.3 (1.06%)

07:04
12/15/17
12/15
07:04
12/15/17
07:04
Hot Stocks
Ritchie Bros. sess $50M+ of equipment in final Fort Worth, TX auction of 2017 »

This week Ritchie Bros.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$43.09

-0.83 (-1.89%)

, ALNY

Alnylam

$123.66

-1.2 (-0.96%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Hot Stocks
Sanofi says FDA lifts clinical hold on fitusiran »

Sanofi Genzyme, the…

SNY

Sanofi

$43.09

-0.83 (-1.89%)

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Mar

  • 02

    May

CROX

Crocs

$10.94

-0.34 (-3.01%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Upgrade
Crocs rating change  »

Crocs upgraded to Buy on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 08

    Jan

ESNC

EnSync

$0.44

0.0663 (17.79%)

, CHTR

Charter

$328.68

-0.32 (-0.10%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Hot Stocks
EnSync: Spectrum solar plus storage project commissioned in Hawaii »

EnSync (ESNC) announces…

ESNC

EnSync

$0.44

0.0663 (17.79%)

CHTR

Charter

$328.68

-0.32 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

PFGC

Performance Food Group

$30.55

-0.9 (-2.86%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Hot Stocks
Performance Food Group appoints Jim Hope as CFO »

Performance Food Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

ACRS

Aclaris Therapeutics

$24.72

-0.38 (-1.51%)

07:02
12/15/17
12/15
07:02
12/15/17
07:02
Hot Stocks
Aclaris Therapeutics receives FDA approval for Eskata topical solution, 40% »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

AER

AerCap

$52.12

-0.46 (-0.87%)

07:01
12/15/17
12/15
07:01
12/15/17
07:01
Recommendations
AerCap analyst commentary  »

AerCap book value can hit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTWO

Q2 Holdings

$37.30

-0.75 (-1.97%)

07:00
12/15/17
12/15
07:00
12/15/17
07:00
Recommendations
Q2 Holdings analyst commentary  »

Q2 Holdings has strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

07:00
12/15/17
12/15
07:00
12/15/17
07:00
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$6.82

-0.2 (-2.85%)

06:59
12/15/17
12/15
06:59
12/15/17
06:59
Downgrade
Fitbit rating change  »

Fitbit downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,174.80

10.61 (0.91%)

06:55
12/15/17
12/15
06:55
12/15/17
06:55
Periodicals
Luxembourg appeals EU order to recover tax from Amazon, Reuters reports »

Luxembourg is appealing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ACRS

Aclaris Therapeutics

$24.72

-0.38 (-1.51%)

06:55
12/15/17
12/15
06:55
12/15/17
06:55
Hot Stocks
Breaking Hot Stocks news story on Aclaris Therapeutics »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

GDX

Market Vector Gold Miners

$22.07

-0.09 (-0.41%)

06:54
12/15/17
12/15
06:54
12/15/17
06:54
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$110.57

2.96 (2.75%)

, FOXA

21st Century Fox

$34.88

2.13 (6.50%)

06:54
12/15/17
12/15
06:54
12/15/17
06:54
Recommendations
Disney, 21st Century Fox analyst commentary  »

Disney price target…

DIS

Disney

$110.57

2.96 (2.75%)

FOXA

21st Century Fox

$34.88

2.13 (6.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

GLD

SPDR Gold Trust

$118.93

-0.24 (-0.20%)

06:54
12/15/17
12/15
06:54
12/15/17
06:54
Technical Analysis
SPDR Gold Trust: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$26.83

-0.31 (-1.14%)

06:52
12/15/17
12/15
06:52
12/15/17
06:52
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.